Orexin gene expression is increased during states of hypertriglyceridemia

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  Wortley, Katherine E ^a   Chang, Guo Qing ^a   Davydova, Zoya ^a   Leibowitz, Sarah F ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

High fat diet; Obesity; Perifornical lateral hypothalamus; Triglycerides

Indexed keywords

DNA; GALANIN; GLUCOSE; INSULIN; INTRALIPID; LEPTIN; MESSENGER RNA; OREXIN; TRIACYLGLYCEROL; CARRIER PROTEIN; COLCHICINE; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; ENERGY BALANCE; GENE EXPRESSION; HYPERPHAGIA; HYPERTRIGLYCERIDEMIA; HYPOTHALAMUS; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; LIPID DIET; MALE; METABOLITE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BLOOD; DRUG EFFECT; FAT INTAKE; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; METABOLISM; MOUSE STRAIN; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CARRIER PROTEINS; COLCHICINE; DIETARY FATS; GALANIN; GENE EXPRESSION REGULATION; HYPERTRIGLYCERIDEMIA; HYPOTHALAMUS; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MALE; MICE; MICE, INBRED STRAINS; NEUROPEPTIDES; OBESITY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRIGLYCERIDES;

EID: 0037844739     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00286.2002     Document Type: Article

References (65)

1. Adkins ES, Salman FT, and Fonkalsrud EW. Triglyceride absorption in transperitoneal alimentation. Am J Surg 159: 237-240, 1990.
2. American Physiology Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281-R283, 2002.
3. Antunes VR, Brailoiu GC, Kwok EH, Scruggs P, and Dun NJ. Orexins/hypocretins excite rat sympathetic preganglionic neurons in vivo and in vitro. Am J Physiol Regul Integr Comp Physiol 281: R1801-R1807, 2001.
4. Bahceci M, Tuzcu A, Akkus M, Yaldiz M, and Ozbay A. The effect of high-fat diet on the development of obesity and serum leptin level in rats. Eat Weight Disord 4: 128-132, 1999.
5. Bayer L, Mairet-Coello G, Risold PY, and Griffond B. Orexin/hypocretin neurons: chemical phenotype and possible interactions with melanin-concentrating hormone neurons. Regul Pept 104: 33-39, 2002.
6. Beck B and Richy S. Hypothalamic hypocretin/orexin and neuropeptide Y: divergent interaction with energy depletion and leptin. Biochem Biophys Res Commun 258: 119-122, 1999.
7. Beck B, Richy S, Dimitrov T, and Stricker-Krongrad A. Opposite regulation of hypothalamic orexin and neuropeptide Y receptors and peptide expressions in obese Zucker rats. Biochem Biophys Res Commun 286: 518-523, 2001.
8. Bhathena SJ. Comparison of effects of decapitation and anesthesia on metabolic and hormonal parameters in Sprague-Dawley rats. Life Sci 50: 1649-1655, 1992.
9. Cai XJ, Evans ML, Lister CA, Leslie RA, Arch JR, Wilson S, and Williams G. Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract. Diabetes 50: 105-112, 2001.
10. Cai XJ, Lister CA, Buckingham RE, Pickavance L, Wilding J, Arch JR, Wilson S, and Williams G. Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and Zucker diabetic fatty rats and effects of rosiglitazone. Mol Brain Res 77: 131-137, 2000.
11. Cai XJ, Widdowson PS, Harrold J, Wilson S, Buckingham RE, Arch JR, Tadayyon M, Clapham JC, Wilding J, and Williams G. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes 48: 2132-2137, 1999.
12. Chen Y, Bender RA, Frotscher M, and Baram TZ. Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J Neurosci 21: 7171-7181, 2001.
13. Commerford SR, Pagliassotti MJ, Melby CL, Wei Y, and Hill JO. Inherent capacity for lipogenesis or dietary fat retention is not increased in obesity-prone rats. Am J Physiol Regul Integr Comp Physiol 280: R1680-R1687, 2001.
14. Cowley MA, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, and Low MJ. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411: 480-484, 2001.
15. Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, Sakurai T, Yanagisawa M, and Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA 96: 748-753, 1999.
16. De Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, Frankel WN, Van Den Pol AN, Bloom FE, Gautvik KM, and Sutcliffe JG. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322-327, 1998.
17. Dobrian AD, Davies MJ, Prewitt RL, and Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension 35: 1009-1015, 2000.
18. Dube MG, Horvath TL, Kalra PS, and Kalra SP. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats. Peptides 21: 1557-1560, 2000.
19. Dun NJ, Le Dun S, Chen CT, Hwang LL, Kwok EH, and Chang JK. Orexins: a role in medullary sympathetic outflow. Regul Pept 96: 65-70, 2000.
20. Eberle AN, Baker BI, Kishida M, Baumann JB, and Girard J. Melanin concentrating hormone. IV. Development of a sensitive solid-phase radioimmunoassay for melanin-concentrating hormone. Life Sci 45: 1149-1154, 1989.
21. Elias CF, Lee C, Kelly J, Aschkenasi C, Ahima RS, Couceyro PR, Kuhar MJ, Saper CB, and Elmquist JK. Leptin activates hypothalamic CART neurons projecting to the spinal cord. Neuron 21: 1375-1385, 1998.
22. Estabrooke IV, McCarthy MT, Ko E, Chou TC, Chemelli RM, Yanagisawa M, Saper CB, and Scammell TE. Fos expression in orexin neurons varies with behavioral state. J Neurosci 21: 1656-1662, 2001.
23. Fadel J, Bubser M, and Deutch AY. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. J Neurosci 22: 6742-6746, 2002.
24. Gremlich S, Bonny C, Waeber G, and Thorens B. Fatty acids decrease IDX-1 expression in rat pancreatic islets and reduce GLUT2, glucokinase, insulin, and somatostatin levels. J Biol Chem 272: 30261-30269, 1997.
25. Griffond B, Risold PY, Jacquemard C, Colard C, and Fellmann D. Insulin-induced hypoglycemia increases preprohypocretin (orexin) mRNA in the rat lateral hypothalamic area. Neurosci Lett 262: 77-80, 1999.
26. Guan JL, Saotome T, Wang QP, Funahashi H, Hori T, Tanaka S, and Shioda S. Orexinergic innervation of POMC-containing neurons in the rat arcuate nucleus. Neuroreport 12: 547-551, 2001.
27. Hakansson M, de Lecea L, Sutcliffe JG, Yanagisawa M, and Meister B. Leptin receptor- and STAT3-immunoreactivities in hypocretin/orexin neurones of the lateral hypothalamus. J Neuroendocrinol 11: 653-663, 1999.
28. Han S, Chen X, Wu YM, Naes L, and Westfall T. Elevated neuropeptide Y gene expression and release during hypoglycemic stress. Peptides 18: 1335-1340, 1997.
29. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, and Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30: 345-354, 2001.
30. Haynes AC, Chapman H, Taylor C, Moore GB, Cawthorne MA, Tadayyon M, Clapham JC, and Arch JR. Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice. Regul Pept 104: 153-159, 2002.
31. Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, Porter RA, and Arch JR. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept 96: 45-51, 2000.
32. Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, and Arch JR. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat. Peptides 20: 1099-1105, 1999.
33. Jain MR, Horvath TL, Kalra PS, and Kalra SP. Evidence that NPY Y1 receptors are involved in stimulation of feeding by orexins (hypocretins) in sated rats. Regul Pept 87: 19-24, 2000.
34. Kilduff TS and Peyron C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci 23: 359-365, 2000.
35. Lagarde M, Bernoud N, Brossard N, Lemaitre-Delaunay D, Thies F, Croset M, and Lecerf J. Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. J Mol Neurosci 16: 201-204, 2001.
36. Leibowitz SF, Akabayashi A, and Wang J. Obesity on a high-fat diet: role of hypothalamic galanin in neurons of the anterior paraventricular nucleus projecting to the median eminence. J Neurosci 18: 2709-2719, 1998.
37. Lopez M, Seoane L, Garcia MC, Lago F, Casanueva FF, Senaris R, and Dieguez C. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun 269: 41-45, 2000.
38. Lubkin M and Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 253: 241-245, 1998.
39. Mahedero G, Moran JM, Salas J, and Blanco M. Absorption of Intralipid and interferences from nutrients infused into the peritoneal cavity of the rat. Am J Surg 164: 45-50, 1992.
40. Mortimer BC, Umeda Y, Elsegood CL, and Redgrave TG. Effects of anaesthesia on the removal from plasma of intravenously injected chylomicron-like lipid emulsions in rats and mice. Clin Exp Pharmacol Physiol 20: 51-58, 1993.
41. Muroya S, Uramura K, Sakurai T, Takigawa M, and Yada T. Lowering glucose concentrations increases cytosolic Ca{%N}2+{%N} in orexin neurons of the rat lateral hypothalamus. Neurosci Lett 309: 165-168, 2001.
42. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, and Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res 827: 243-260, 1999.
43. Oomura Y, Nakamura T, Sugimori M, and Yamada Y. Effect of free fatty acid on the rat lateral hypothalamic neurons. Physiol Behav 14: 483-486, 1975.
44. Oomura Y, Ono T, Ooyama H, and Wayner MJ. Glucose and osmosensitive neurones of the rat hypothalamus. Nature 222: 282-284, 1969.
45. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates (2nd ed.). Sydney: Academic, 1986.
46. Rohner-Jeanrenaud F, Craft LS, Bridwell J, Suter TM, Tinsley FC, Smiley DL, Burkhart DR, Statnick MA, Heiman ML, Ravussin E, and Caro JF. Chronic central infusion of cocaine- and amphetamine-regulated transcript (CART 55-102): effects on body weight homeostasis in lean and high-fat-fed obese rats. Int J Obes Relat Metab Disord 26: 143-149, 2002.
47. Sahu A, Kalra PS, and Kalra SP. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides 9: 83-86, 1988.
48. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, and Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573-585, 1998.
49. Shirasaka T, Nakazato M, Matsukura S, Takasaki M, and Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol Regul Integr Comp Physiol 277: R1780-R1785, 1999.
50. Shor-Posner G, Brennan G, Ian C, Jasaitis R, Madhu K, and Leibowitz SF. Meal patterns of macronutrient intake in rats with particular dietary preferences. Am J Physiol Regul Integr Comp Physiol 266: R1395-R1402, 1994.
51. Stricker-Krongrad A, Richy S, and Beck B. Orexins/hypocretins in the ob/ob mouse: hypothalamic gene expression, peptide content and metabolic effects. Regul Pept 104: 11-20, 2002.
52. Sweet DC, Levine AS, Billington CJ, and Kotz CM. Feeding response to central orexins. Brain Res 821: 535-538, 1999.
53. Taheri S, Mahmoodi M, Opacka-Juffry J, Ghatei MA, and Bloom SR. Distribution and quantification of immunoreactive orexin A in rat tissues. FEBS Lett 457: 157-161, 1999.
54. Wang H, Storlien LH, and Huang XF. Influence of dietary fats on c-Fos-like immunoreactivity in mouse hypothalamus. Brain Res 843: 184-192, 1999.
55. Wang J, Alexander JT, Zheng P, Yu HJ, Dourmashkin J, and Leibowitz SF. Behavioral and endocrine traits of obesityprone and obesity-resistant rats on macronutrient diets. Am J Physiol Endocrinol Metab 274: E1057-E1066, 1998.
56. Wang ZW, Zhou YT, Kakuma T, Lee Y, Higa M, Kalra SP, Dube MG, Kalra PS, and Unger RH. Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia. Proc Natl Acad Sci USA 96: 10373-10378, 1999.
57. Watkins PA, Hamilton JA, Leaf A, Spector AA, Moore SA, Anderson RE, Moser HW, Noetzel MJ, and Katz R. Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases. J Mol Neurosci 16: 87-92, 2001.
58. Welch CC, Kim EM, Grace MK, Billington CJ, and Levine AS. Palatability-induced hyperphagia increases hypothalamic dynorphin peptide and mMRNA levels. Brain Res 721: 126-131, 1996.
59. West DB, Boozer CN, Moody DL, and Atkinson RL. Dietary obesity in nine inbred mouse strains. Am J Physiol Regul Integr Comp Physiol 262: R1025-R1032, 1992.
60. Wise RA. Addiction becomes a brain disease. Neuron 26: 27-33, 2000.
61. Yamada H, Okumura T, Motomura W, Kobayashi Y, and Kohgo Y. Inhibition of food intake by central injection of antiorexin antibody in fasted rats. Biochem Biophys Res Commun 267:527-531, 2000.
62. Yamamoto Y, Ueta Y, Date Y, Nakazato M, Hara Y, Serino R, Nomura M, Shibuya I, Matsukura S, and Yamashita H. Down regulation of the prepro-orexin gene expression in genetically obese mice. Mol Brain Res 65: 14-22, 1999.
63. Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I, Miwa Y, Goto K, and Sakurai T. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res 859:404-409, 2000.
64. Yoshida Y, Fujiki N, Nakajima T, Ripley B, Matsumura H, Yoneda H, Mignot E, and Nishino S. Fluctuation of extracellular hypocretin-1 (orexin A) levels in the rat in relation to the light-dark cycle and sleep-wake activities. Eur J Neurosci 14: 1075-1081, 2001.
65. Ziotopoulou M, Mantzoros CS, Hileman SM, and Flier JS. Differential expression of hypothalamic neuropeptides in the early phase of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 279: E838-E845, 2000.